Key facts
- This page summarizes Niamh Louise Pellegrini's Form 4 filing for NEVRO CORP.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 31 May 2023, 19:02.
Niamh Louise Pellegrini - 28 May 2023 Form 4 Insider Report for NEVRO CORP
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- N/A
- Reported as of
- 28 May 2023
- Net transaction value
- -$30,232
- SEC form
- 4
- Accepted by SEC
- 31 May 2023, 19:02:02 UTC
- Prior SEC filing
- 09 Mar 2023
- Next SEC filing
- 15 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kashif Rashid, as Attorney-in-Fact for Niamh Louise Pellegrini
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Niamh Louise Pellegrini filed Form 4 for NEVRO CORP on 31 May 2023.
Change
- Previous filing in this sequence was filed on 09 Mar 2023.
- Current net transaction value: -$30,232.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NVRO
transaction
Common Stock
Tax liability
- Transaction value
- $30,232
- Shares
- -1,143
- Change %
- -1.3%
- Price
- $26.45
- Shares after
- 85,967
- Date
- 28 May 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Includes 68,942 restricted stock units.